Nanoceria Can Act as the Cues for Angiogenesis in Tissue-Engineering Scaffolds: Toward Next-Generation in Situ Tissue Engineering.

Fiche publication

Date publication

décembre 2018

Journal

ACS biomaterials science & engineering

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MENU Patrick

Tous les auteurs :
Augustine R, Dalvi YB, Dan P, George N, Helle D, Varghese R, Thomas S, Menu P, Sandhyarani N

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33418829

Résumé

Next-generation tissue engineering exploits the body's own regenerative capacity by providing an optimal niche via a scaffold for the migration and subsequent proliferation of endogenous cells to the site of injury, enhancing regeneration and healing and bypassing laborious in vitro cell-culturing procedures. Such systems are also required to have a sufficient angiogenic capacity for the subsequent patency of implanted scaffolds. The exploitation of redox properties of nanodimensional ceria (nCeO) in in situ tissue engineering to promote cell adhesion and angiogenesis is poorly investigated. As a novel strategy, electrospun polycaprolactone based tissue-engineering scaffolds loaded with nCeO were developed and evaluated for morphological and physicomechanical features. In addition, in vitro and in vivo studies were performed to show the ability of nCeO-containing scaffolds to enhance cell adhesion and angiogenesis. These studies confirmed that nCeO-containing scaffolds supported cell adhesion and angiogenesis better than bare scaffolds. Gene-expression studies had shown that angiogenesis-related factors such as HIF1α and VEGF were up-regulated. Overall results show that incorporation of nCeO plays a key role in scaffolds for the enhancement of angiogenesis, cell adhesion, and cell proliferation and can produce a successful outcome in in situ tissue engineering.